A Case of Localized Erythematous Dermatitis on the Site of a Docetaxel Injection.

Abstract

Docetaxel is a taxoid antineoplastic drug widely used for various advanced solid tumors. Docetaxel-induced cutaneous adverse reactions include acral erythema, pigmentaion disorders and nail changes. Herein we report a case of recurrent erythematous dermatitis which was localized on the site of a docetaxel injection in a 48-year-old patient with advanced gastric cancer. Histopathological findings were consistent with erythema multiforme